Table 1 Basic characteristics
From: Metabolic syndrome components and acute pancreatitis: a case–control study in China
Non-AP patients (n = 356) | AP patients (n = 349) | p | |
|---|---|---|---|
Mean age, years (SD) | 51.2 ± 15.9 | 51.2 ± 15.9 | 0.989 |
Gender, n (%) | |||
Female | 140 (39.3) | 136 (39.0) | |
Male | 216 (60.7) | 213 (61.0) | 0.923 |
Smoking history, n (%) | 62 (17.4) | 125 (35.8) | < 0.001 |
Alcohol drinking history, n (%) | 53 (14.9) | 101 (28.9) | < 0.001 |
Biliary stones, n (%) | 8 (2.3) | 101 (28.9) | < 0.001 |
Hepatitis B, n (%) | 17 (4.8) | 7 (2.0) | 0.049 |
Hepatitis C, n (%) | 3 (0.8) | 1 (0.3) | 0.349 |
BMI, kg/m2 (IQR) | 23.8 ± 3.5 | 24.8 ± 3.7 | < 0.001 |
TC, mg/dL (IQR) | 178.0 (153.7, 209.3) | 180.3 (145.6, 235.1) | < 0.001 |
TG, mg/dL (IQR) | 101.8 (77.0, 157.5) | 131.9 (81.4, 349.6) | < 0.001 |
HDL, mg/dL (IQR) | 99.1 (86.7, 117.7) | 90.3 (74.3, 112.4) | < 0.001 |
LDL, mg/dL (IQR) | 269.9 (224.8, 318.6) | 258.4 (198.2, 236.3) | 0.030 |
Apo A, g/L (IQR) | 1.2 (1.1, 1.4) | 1.1 (0.9, 1.3) | < 0.001 |
Apo B, g/L (IQR) | 0.9 (0.7, 1.0) | 0.8 (0.7, 1.0) | 0.198 |
FPG, mg/dL (IQR) | 97.8 (89.4, 112.1) | 132.8 (107.4, 172.7) | < 0.001 |
Anti-diabetic therapy, n (%) | 27 (79.4) | 59 (64.8) | 0.118 |